Skip to main content
. 2024 Dec 4;46:e-rbgo93. doi: 10.61622/rbgo/2024rbgo93

Figure 2. Left ventricular ejection fraction (LVEF) measures for patients with and without cardiotoxicity during adjuvant treatment with trastuzumab.

Figure 2